Colgate-Palmolive (CL) Receives Consensus Recommendation of “Hold” from Brokerages

Shares of Colgate-Palmolive (NYSE:CL) have been assigned a consensus rating of “Hold” from the nineteen brokerages that are currently covering the company, Marketbeat Ratings reports. Three investment analysts have rated the stock with a sell recommendation, eleven have issued a hold recommendation and five have given a buy recommendation to the company. The average twelve-month target price among brokers that have updated their coverage on the stock in the last year is $77.71.

A number of research analysts have issued reports on the stock. Jefferies Group reissued a “hold” rating and set a $79.00 price objective on shares of Colgate-Palmolive in a research report on Friday, January 26th. Societe Generale downgraded shares of Colgate-Palmolive from a “hold” rating to a “sell” rating and set a $66.00 price objective on the stock. in a research report on Wednesday, November 29th. They noted that the move was a valuation call. Zacks Investment Research downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Friday, January 5th. Citigroup reduced their price objective on shares of Colgate-Palmolive from $76.00 to $75.00 and set a “neutral” rating on the stock in a research report on Thursday, November 2nd. Finally, Stifel Nicolaus set a $73.00 price objective on shares of Colgate-Palmolive and gave the company a “hold” rating in a research report on Sunday, October 29th.

Colgate-Palmolive (CL) opened at $69.76 on Tuesday. The company has a current ratio of 0.47, a quick ratio of 0.34 and a debt-to-equity ratio of 24.42. The stock has a market cap of $61,256.62, a price-to-earnings ratio of 30.60, a price-to-earnings-growth ratio of 2.58 and a beta of 0.75. Colgate-Palmolive has a 1 year low of $66.47 and a 1 year high of $77.91.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, January 26th. The company reported $0.75 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $0.75. The business had revenue of $3.89 billion for the quarter, compared to the consensus estimate of $3.92 billion. Colgate-Palmolive had a net margin of 13.10% and a return on equity of 1,716.69%. The company’s quarterly revenue was up 4.6% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.75 EPS. equities research analysts predict that Colgate-Palmolive will post 3.18 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, February 15th. Investors of record on Tuesday, January 23rd will be given a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 2.29%. The ex-dividend date of this dividend is Monday, January 22nd. Colgate-Palmolive’s dividend payout ratio (DPR) is 70.18%.

In related news, Vice Chairman Franck J. Moison sold 142,979 shares of the stock in a transaction dated Tuesday, February 6th. The shares were sold at an average price of $70.09, for a total transaction of $10,021,398.11. Following the sale, the insider now directly owns 224,027 shares of the company’s stock, valued at approximately $15,702,052.43. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Jennifer Daniels sold 902 shares of the stock in a transaction dated Tuesday, January 9th. The shares were sold at an average price of $75.82, for a total transaction of $68,389.64. Following the sale, the insider now directly owns 37,788 shares in the company, valued at $2,865,086.16. The disclosure for this sale can be found here. Insiders have sold a total of 327,451 shares of company stock worth $23,534,707 over the last three months. 1.02% of the stock is currently owned by insiders.

A number of institutional investors and hedge funds have recently bought and sold shares of CL. Beach Investment Management LLC. bought a new position in Colgate-Palmolive during the 2nd quarter valued at about $3,954,000. BP PLC lifted its stake in Colgate-Palmolive by 22.5% during the 2nd quarter. BP PLC now owns 136,000 shares of the company’s stock valued at $10,082,000 after acquiring an additional 25,000 shares during the period. Pioneer Investment Management Inc. lifted its stake in Colgate-Palmolive by 27.8% during the 2nd quarter. Pioneer Investment Management Inc. now owns 2,061,196 shares of the company’s stock valued at $152,796,000 after acquiring an additional 447,949 shares during the period. Legacy Capital Partners Inc. lifted its stake in Colgate-Palmolive by 1.9% during the 2nd quarter. Legacy Capital Partners Inc. now owns 56,640 shares of the company’s stock valued at $4,199,000 after acquiring an additional 1,050 shares during the period. Finally, Summit Financial Group Inc. bought a new position in Colgate-Palmolive during the 2nd quarter valued at about $1,206,000. Institutional investors and hedge funds own 72.85% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Colgate-Palmolive (CL) Receives Consensus Recommendation of “Hold” from Brokerages” was published by American Banking News and is owned by of American Banking News. If you are reading this report on another domain, it was copied illegally and republished in violation of U.S. and international copyright law. The correct version of this report can be accessed at https://www.americanbankingnews.com/2018/02/06/colgate-palmolive-cl-receives-average-rating-of-hold-from-brokerages.html.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Analyst Recommendations for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply